BTIG and Wells Fargo Maintain Buy Ratings for Adaptive Biotechnologies and Affirm

BTIG maintained a Buy rating on Adaptive Biotechnologies (ADPT), and Wells Fargo also maintained a Buy rating on Affirm Holdings (AFRM). These firms continue to recommend these stocks to investors.